\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ gamma\\ knife\\ radiation\ \(2\)\
\-\ \\â\\€\\¢\\ large\\ mass\\ which\\ is\\ predominately\\ intraventricular\\ but\\ which\\ also\\ involves\\ adjacent\\ white\\ matter\\.\ \(0\)\
\-\ \\â\\€\\¢\\ low\\ signal\\ intensity\\ of\\ t2\\ images\\ probably\\ due\\ to\\ calcium\\.\ \(0\)\
\-\ \\â\\€\\¢\\ uniform\\ contrast\\ enhancement\ \(0\)\
\-\ brain\\,\\ choroid\\ plexus\\,metastatic\\ colon\\ carcinoma\ \(0\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ papilloma\\/carcinoma\ \(1\)\
\-\ \\â\\€\\¢\\ choroid\\ plexus\\ metastasis\ \(0\)\
\-\ \\â\\€\\¢\\ xanthogranuloma\\ of\\ choroid\\ plexus\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ ependymoma\ \(8\)\
\-\ 62\\ year\\ old\\ man\\ with\\ known\\ adenocarcinoma\\ of\\ the\\ colon\\ presents\\ with\\ headache\ \(1\)\
\-\ patient\\ also\\ had\\ metastatic\\ disease\\ to\\ adrenal\\ glands\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ choroid\\:\\ 0\\.21274005501038976\ \(0\)\
\-\ plexus\\:\\ 0\\.20254045511485033\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1528794489361842\ \(0\)\
\-\ papilloma\\/carcinoma\\:\\ 0\\.09410861140607792\ \(0\)\
\-\ xanthogranuloma\\:\\ 0\\.09060029344934888\ \(0\)\
\-\ colon\\:\\ 0\\.08185202219078877\ \(0\)\
\-\ predominately\\:\\ 0\\.06686968187550359\ \(0\)\
\-\ knife\\:\\ 0\\.06562842950587015\ \(0\)\
\-\ gamma\\:\\ 0\\.06314551541756235\ \(0\)\
\-\ glands\\:\\ 0\\.06192498543516012\ \(0\)\
\-\ uniform\\:\\ 0\\.06108360895361194\ \(0\)\
\-\ intraventricular\\:\\ 0\\.060553302710444394\ \(0\)\
\-\ 62\\:\\ 0\\.05698028899481666\ \(0\)\
\-\ probably\\:\\ 0\\.05552242130396565\ \(0\)\
\-\ adrenal\\:\\ 0\\.05276685431993121\ \(0\)\
\-\ metastatic\\:\\ 0\\.052466083015026595\ \(0\)\
\-\ calcium\\:\\ 0\\.050985237021181254\ \(0\)\
\-\ involves\\:\\ 0\\.048430869969608624\ \(0\)\
\-\ ependymoma\\:\\ 0\\.046647388258387344\ \(0\)\
\-\ adenocarcinoma\\:\\ 0\\.045018956641015115\ \(0\)\
\-\ also\\:\\ 0\\.04108828277244272\ \(0\)\
\-\ matter\\:\\ 0\\.041030243541473145\ \(0\)\
\-\ meningioma\\:\\ 0\\.040074260200671646\ \(0\)\
\-\ metastasis\\:\\ 0\\.03900911373536496\ \(0\)\
\-\ which\\:\\ 0\\.03890596554250119\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.03848824644154728\ \(0\)\
\-\ intensity\\:\\ 0\\.037666715565601236\ \(0\)\
\-\ headache\\:\\ 0\\.03579250533616827\ \(0\)\
\-\ white\\:\\ 0\\.03456224649648802\ \(0\)\
\-\ radiation\\:\\ 0\\.034198185970272396\ \(0\)\
\-\ known\\:\\ 0\\.03297623273736366\ \(0\)\
\-\ adjacent\\:\\ 0\\.032949222489442286\ \(0\)\
\-\ brain\\:\\ 0\\.031357945406131245\ \(0\)\
\-\ carcinoma\\:\\ 0\\.02953570329287642\ \(0\)\
\-\ t2\\:\\ 0\\.02949498498476039\ \(0\)\
\-\ low\\:\\ 0\\.028977659181297556\ \(0\)\
\-\ enhancement\\:\\ 0\\.02793278983076873\ \(0\)\
\-\ due\\:\\ 0\\.02780825796283951\ \(0\)\
\-\ signal\\:\\ 0\\.027476516222838764\ \(0\)\
\-\ man\\:\\ 0\\.024645510281585358\ \(0\)\
\-\ contrast\\:\\ 0\\.023326532765950064\ \(0\)\
\-\ large\\:\\ 0\\.02278710282720829\ \(0\)\
\-\ had\\:\\ 0\\.02248597340537449\ \(0\)\
\-\ but\\:\\ 0\\.02222565001260412\ \(0\)\
\-\ presents\\:\\ 0\\.02128834506716983\ \(0\)\
\-\ images\\:\\ 0\\.0199910230725531\ \(0\)\
\-\ disease\\:\\ 0\\.017033384648972003\ \(0\)\
\-\ mass\\:\\ 0\\.01449342691399469\ \(0\)\
\-\ year\\:\\ 0\\.011659820356986766\ \(0\)\
\-\ old\\:\\ 0\\.010669934108076276\ \(0\)\
\-\ patient\\:\\ 0\\.01044624305995595\ \(0\)\
\-\ to\\:\\ 0\\.010416295327877714\ \(0\)\
\-\ is\\:\\ 0\\.006857204614447874\ \(0\)\
\-\ \\,\\:\\ 0\\.006602684524811888\ \(0\)\
\-\ of\\:\\ 0\\.0042623341755361616\ \(0\)\
\-\ with\\:\\ 0\\.002853760392436335\ \(0\)\
\-\ the\\:\\ 0\\.001685966886629583\ \(0\)\
\-\ \\.\\:\\ 0\\.001298763515756571\ \(0\)\
